AVITA Medical (RCEL) to Release Quarterly Earnings on Thursday

AVITA Medical (NASDAQ:RCEL) will issue its quarterly earnings data after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of ($0.41) per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link.

AVITA Medical (NASDAQ:RCEL) last announced its quarterly earnings results on Thursday, August 8th. The company reported ($0.60) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.59) by ($0.01). AVITA Medical had a negative net margin of 92.04% and a negative return on equity of 118.27%. The company had revenue of $15.20 million for the quarter, compared to analyst estimates of $15.04 million. During the same quarter in the prior year, the business earned ($0.41) earnings per share. On average, analysts expect AVITA Medical to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

AVITA Medical Price Performance

Shares of RCEL opened at $10.39 on Thursday. AVITA Medical has a 1-year low of $7.51 and a 1-year high of $18.93. The stock has a market cap of $270.04 million, a PE ratio of -5.90 and a beta of 1.54. The firm has a 50-day simple moving average of $10.06 and a two-hundred day simple moving average of $9.25. The company has a debt-to-equity ratio of 1.71, a current ratio of 5.29 and a quick ratio of 4.81.

Analyst Ratings Changes

Separately, Cantor Fitzgerald reiterated an “overweight” rating and set a $21.00 price target on shares of AVITA Medical in a research report on Friday, August 9th.

AVITA Medical Company Profile

AVITA Medical, Inc, together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions.